Skip to content
Search

Latest Stories

Taxi and ambulance drivers 'less likely to die' from Alzheimer's

Working in these professions may have a protective effect against Alzheimer's disease

Taxi and ambulance drivers 'less likely to die' from Alzheimer's

Taxi and ambulance drivers had the lowest proportion of deaths due to Alzheimer's disease.

Getty Images/iStockphoto

DEATHS due to Alzheimer's disease were found to be lowest among taxi and ambulance drivers, who frequently process spatial and navigational information, according to a new study.

The findings, published in the British Medical Journal, suggest that working in these professions may have a protective effect against Alzheimer's disease, an age-related condition that progressively deteriorates memory, thinking, and daily functioning.


Researchers, including those from Massachusetts General Hospital, analysed death data from the US National Vital Statistics System for adults across 443 different occupations.

Of the nearly nine million people whose occupational information was available, almost four percent had Alzheimer's disease listed as a cause of death, the researchers found.

Among the 16,658 taxi drivers, about one percent (171) died from Alzheimer's disease, while 10 of 1,348 ambulance drivers (0.74 per cent) died from the neurodegenerative condition.

Compared to the general population and all other occupations examined, taxi and ambulance drivers had the lowest proportion of deaths due to Alzheimer's disease.

This trend was not observed in other transport-related jobs, such as bus drivers or aircraft pilots, possibly due to their reliance on pre-determined routes, the authors noted.

They also pointed out that the trend was not seen in individuals suffering from other forms of dementia, suggesting that neurological changes in the brain's hippocampus region -- or elsewhere -- among taxi and ambulance drivers may explain the reduced Alzheimer's risk.

The hippocampus, a brain region involved in memory, learning, and decision-making, plays a critical role in spatial memory and navigation. This area is also known to be affected in Alzheimer's disease.

The authors referenced a previous study showing that London taxi drivers had an enhanced hippocampus compared to the general population.

However, as this was an observational study, the researchers cautioned that no cause-and-effect conclusions could be drawn.

"In an analysis of nearly all death certificates in the United States, taxi drivers and ambulance drivers, whose jobs require frequent spatial and navigational processing, were found to be the occupations with the two lowest risk-adjusted percentages of deaths due to Alzheimer's disease," the authors wrote.

"Further research is necessary to definitively determine whether the spatial cognitive work required in these occupations affects the risk of death from Alzheimer's disease, and whether any cognitive activities can potentially be preventive," they wrote.

(PTI)

More For You

sugary drinks and ice cream

Researchers from the UK and US analysed data from American households between 2004 and 2019

iStock

Global warming may drive higher consumption of sugary drinks and ice cream, study warns

Highlights:

  • Hotter days linked to greater intake of sugary drinks and frozen desserts
  • Lower-income households most affected, research finds
  • Climate change could worsen health risks linked to sugar consumption
  • Study based on 15 years of US household food purchasing data

Sugary consumption rising with heat

People are more likely to consume sugary drinks and ice cream on warmer days, particularly in lower-income households, according to new research. The study warns that climate change could intensify this trend, adding to health risks as global temperatures continue to rise.

Sugar consumption is a major contributor to obesity, diabetes, and cardiovascular disease, and has surged worldwide in recent decades. The findings, published in Nature Climate Change, suggest that rising heat could be nudging more people towards high-sugar products such as soda, juice and ice cream.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less